US ophthalmic gene therapy company Beacon Therapeutics, which is focused on restoring the vision of patients with blinding ...

UK pharma major GSK has appointed Sanjay Gurunathan as senior vice president and global head vaccines and infectious disease ...

Privately-held Italian pharma company Italfarmaco today revealed that the European Commission (EC) has granted conditional ...

Shares in US pharma giant Merck & Co (NYSE: MRK) were nearly 2% higher in early trading Monday.

Shares of Avidity Biosciences (Nasdaq: RNA) were up almost 5% at $38.00 pre-market today, as it announced the accelerated ...

George Medicines, a late-stage UK-based biopharmaceutical company focused on addressing unmet needs in cardiometabolic ...

South Korea’s biosimilar drug developer Samsung Bioepis has announced that the company has entered into a license, ...

Swiss skincare specialist Galderma has announced two-year data from a new interim analysis of a long-term extension study ...

French pharma major Sanofi (Euronext: SAN) has started early global shipments of its monoclonal antibody Beyfortus ...

Knight will have the exclusive rights to distribute, promote, market and sell the products in Canada, and said it will begin ...

As Denmark presses ahead with a major health reform, a coalition of rare disease advocates and clinicians is urging the ...

US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) and French pharma major Sanofi (Euronext: SAN) on Saturday presented ...